Exponential Moving Average

(redirected from EMA)
Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.

Exponential Moving Average

The average price of a security calculated by adding closing prices from the most recent trading days (for example, the last 10 days) and dividing by the number of trading days considered (in this case, 10), with more recent trading days being weighted so that they affect the average more. An exponential moving average is more difficult to calculate than a simple moving average, but it provides a quick look at a security's trend. See also: Moving Average Convergence Divergence, Envelope.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved
References in periodicals archive ?
This is the first analysis by EMA and the FDA that compares the agencies' decisions related to marketing authorisations.
EMA invests time and money to support local voluntary causes and charities.
The EMA has withdrawn its appeal against the High Court ruling as a result of Wework's move into the offices.
class="MsoNormalThey paid a Sh6 million deposit for the land in 2005 through EMA as they awaited City Hall's approval to subdivide it.
The EMA's decision to include MOTREM in the PRIME scheme was supported by data from a Phase 1 clinical trial showing tolerance, preclinical models demonstrating efficacy, and the fact that there is an important and unmet medical need for the treatment of septic shock.
The minister revealed that from an internal survey at the EMA, 95 per cent of the staff there said they would resign if the seat were relocated to Cyprus.
In Ema's dream, Kierkegaard and Njegos concur that terrestrial life torments seekers.
The 2016 MTV EMAs will broadcast on Monday, November 7, at 12.01am UAE time from the Ahoy Rotterdam in Rotterdam.
Becoming part of EMA allows me and my team to focus on our core expertise: EDA part creation, library tools, and services, said Frank Frank, president and CEO of Accelerated Designs.
EMAGMA terpolymer (E = 8 MPa) possess EMA elastomeric blocks that promote flexibility and GMA blocks that are able to react with PLA functional end groups promoting good adhesion between PLA and EMA-GMA.
(1) These plants are stimulant laxatives of well-established therapeutic use according to EMA (2006-2008).
The European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to release its report on clinical trials carried out by AbbVie and InterMune until a final ruling is given by the court.